Friday, June 8, 2012

Reuters: Mergers News: TEXT-S&P revises American Pacific Corp outlook to positive

Reuters: Mergers News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
TEXT-S&P revises American Pacific Corp outlook to positive
Jun 8th 2012, 18:07

Fri Jun 8, 2012 2:07pm EDT

  Overview          -- Las Vegas-based American Pacific Corp. announced it has reached  an agreement to divest its Aerospace Equipment segment for gross proceeds of      approximately $46 million.             -- We are revising our outlook on American Pacific to positive from          stable.                -- At the same time, we are affirming our ratings, including the 'B'         corporate credit rating, on the company.               -- The positive outlook reflects our opinion that improving operating        performance over the next year and the likely use of a majority of the    divestiture proceeds for debt reduction could support credit metrics in line      with slightly higher ratings.     Rating Action     On June 8, 2012, Standard & Poor's Ratings Services revised its outlook on        American Pacific Corp. to positive from stable. At the same time, we affirmed     all our ratings, including the 'B' corporate credit rating, on the company.                 Rationale         The outlook revision follows the company's recent announcement that it has        reached an agreement to sell its Aerospace Equipment segment to Moog Inc.         (BB/Stable/--) for gross proceeds of $46 million. We view the transaction as      neutral to the business risk profile because this segment offered lower           growth, generated somewhat lower EBITDA margins than that of the overall          company, and served the same end markets as the specialty chemicals segment.      However, we expect the company to use the majority of the proceeds to reduce      debt given its focus on strengthening its balance sheet, thus enhancing the       financial risk profile. The outlook revision also reflects our expectation        that American Pacific will sustain the recent improvement in its operating        performance and credit metrics. Total debt (adjusted for capitalized operating    leases, environmental liabilities, and unfunded pension and other         postretirement obligations) to EBITDA improved significantly to 3.3x as of        March 31, 2012, from a trough of 10.6x for the same period the prior year.        Based on our scenario forecasts, the company will likely maintain leverage        between 3x and 4x over the next year, given our expectations for moderate debt    reduction, which the loss of about $5 million in EBITDA from the divested         segment partially offsets.                  The ratings on American Pacific reflect the company's business position as a      niche provider of ammonium perchlorate (AP) and active pharmaceutical     ingredients. The ratings also reflect a narrow customer and product base,         demand that is somewhat dependent on governmental appropriations in the AP        business, and the continued success of a few key drugs in the active      pharmaceutical ingredients business. Partially offsetting these risks are the     company's positions as a sole- and dual-source supplier in markets that           represent a significant portion of its revenues. We characterize the company's    business profile as "weak" and financial profile as "aggressive".                   American Pacific generated approximately $239 million in revenues for the 12      months ended March 31, 2012. The company's fine chemicals business consists of    the production of active pharmaceutical ingredients for pharmaceutical    customers. High switching costs--once a drug receives Food and Drug       Administration (FDA) approval--and limited pricing pressure from the customer     base mitigate the high customer concentration risk for this business. (The        company derives about 86% of this segment's sales from four customers.)           However, it's still exposed to risks associated with FDA approvals of new         products, newer drugs that compete with current drug offerings, and, to a         lesser extent, generic drug competition as patents expire. The loss of a key      customer as a result of one or more of these factors could significantly          affect profitability and cash flows.                The company, through its more-profitable specialty chemicals segment, is the      sole U.S. domestic supplier of AP, a chemical used as an oxidizing agent in       composite solid fuels for rockets and booster motors. A relatively small          number of U.S. Department of Defense (DoD) and NASA contractors generate          demand in this market. Risks inherent in government contracts and dependence      on Congressional appropriations, particularly in an election year, make the       outlook for long-term demand uncertain. Moreover, the company's single    operating facility for AP is subject to hazards associated with chemical          manufacturing and other potential disruptions that could limit production. The    dual lines of production that the company has in place at this facility           mitigate only some of this risk. Although AP customer volume requirements vary    substantially from quarter to quarter, the company conducts a meaningful          portion of its business through contracts that provide some protection against    volume and margin deterioration.                    The continued uncertainty in demand for AP over the next few years reflects       the potential that programs related to NASA and ongoing requirements from the     DoD could affect the level and timing of profits. In fiscal 2011, the company     generated the bulk of earnings in the fourth quarter, primarily as a result of    the timing of orders for AP. However, we expect increased sales and       profitability from a mix of new and existing products in its fine chemicals       segment to somewhat offset the potential for irregular profitability within       its specialty chemicals segment. Earlier this year, the Drug Enforcement          Agency (DEA) approved American Pacific as a bulk manufacturer of schedule II      controlled substances, and the company signed a long-term contract with a         large pharmaceutical customer. We believe the company's penetration into this     area represents a modest revenue growth opportunity.                American Pacific's financial risk profile is aggressive. The key ratio of         funds from operations (FFO) to total debt was 16% as of March 31, 2012, in        line with the 10% to 15% range that we consider appropriate for the rating.       The company's sizeable environmental liabilities relate to the perchlorate        contamination in groundwater near its former Henderson, Nev., site, with about    $23 million reserved for future remediation efforts as of March 31, 2012.         Although we expect this liability to be manageable given its current liquidity    position, remediation may be more challenging or expensive than we expect.                  Liquidity         We expect liquidity to remain "adequate" with cash sources that will more than    cover needs over the next 18 to 24 months. As of March 31, 2012, American         Pacific had about $21 million in cash and no borrowings under $20 million         asset-based lending (ABL) facility. Based on our scenario forecast, we do not     expect the company will need to use this facility in fiscal-year 2012.    Instead, we expect it to fund its near-term liquidity needs through its cash      flows and existing cash balances.                   Based on our scenario forecast, we expect free cash flow to be neutral in the     fiscal year ending September 2012, with about $13 million in capital      expenditures and about $12 million in remediation spending, mostly related to     its former Henderson site. Debt maturities are manageable, with no significant    scheduled maturities until November 2014 when the ABL facility would come due     if the senior notes are not refinanced.             There are no maintenance financial covenants in the credit agreement. However,    the ABL facility has springing financial covenants that apply when the company    uses the facility and if availability falls below $5 million. The springing       financial covenants include a 1.1x fixed-charge covenant and an annual capital    expenditure limit of $21.5 million. Based on our scenario forecasts, we do not    expect the company will use its ABL facility and, therefore, it should not be     subject to the springing covenants in the next few quarters.                Relevant aspects of our assessment of the company's liquidity profile include:                   -- We expect the company's sources of liquidity to exceed its uses by        1.2x or more over the next 12 to 24 months;            -- Net sources would be positive even with a 15% drop in EBITDA; and              -- American Pacific would likely be able to absorb low-probability shocks    based on available liquidity.                         Recovery analysis         For the complete recovery analysis, see our recovery report on American           Pacific, published Feb. 24, 2012, on RatingsDirect.                 Outlook   The positive outlook reflects our expectation that the company will use the       divestiture proceeds to moderately reduce debt, thus improving its financial      risk profile. The outlook also reflects our belief that the company's improved    operating performance is sustainable over at least the next year, given its       new product development and increased backlog in the fine chemicals segment.                We could raise the ratings by one notch if the company moderately reduces debt    as we expect, and it is able to increase EBITDA margins by 100 basis points or    more above our expectations. In this scenario, we would expect FFO to total       adjusted debt to approach 20% and that free cash flow would be modestly           positive. We would also need to be more comfortable with the stability and        visibility of American Pacific's future revenue streams.                    However, there could be some volatility in quarterly results because of the       uncertainty regarding the timing of profits, particularly in the specialty        chemicals segment. We could consider a downgrade if the company cannot sustain    recent improvements in operating profitability because of unexpected business     challenges, such as the loss of a key customer. Based on our scenario     forecasts, we could lower the rating if organic revenues decline by 15% or        more from our expectations, coupled with a 300-basis point decline in EBITDA      margins. In this scenario, we would expect FFO to total adjusted debt to          decrease below 10%. We would also consider a downgrade if the remediation of      its environmental liabilities proves to be more challenging than we expect,       with the potential for larger cash outlays.                 Related Criteria And Research          -- Methodology and Assumptions: Liquidity Descriptors For Global     Corporate Issuers, Sept. 28, 2011              -- Criteria Methodology: Business Risk/Financial Risk Matrix Expanded,       May 27, 2009           -- Key Credit Factors: Business And Financial Risks In The Commodity And     Specialty Chemical Industry, Nov. 20, 2008                  Ratings List      Ratings Affirmed; Outlook Action                                                  To                 From   American Pacific Corp.     Corporate Credit Rating                B/Positive/--      B/Stable/--              Ratings Affirmed                    American Pacific Corp.     Senior Unsecured                       B                           Recovery Rating                       4                                             Complete ratings information is available to subscribers of RatingsDirect on      the Global Credit Portal at www.globalcreditportal.com. All ratings affected      by this rating action can be found on Standard & Poor's public Web site at        www.standardandpoors.com. Use the Ratings search box located in the left          column.  
  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

0 comments:

Post a Comment

 
Great HTML Templates from easytemplates.com.